• Amitriptyline HCl: Practical Assay Guide

  2026-08-26

  Amitriptyline HCl (SKU B2231) provides a characterized small-molecule reference for multi-receptor inhibition studies, solution preparation, and neuropharmacology research. It is suited to controlled in vitro workflows with prompt use of freshly prepared solutions, but should not be treated as a validated therapeutic model or used where long-term solution stability has not been established.

• COX-2 in Venom-Induced Muscle Revascularization

  2026-08-25

  This study shows that COX-2 has a time-dependent role in skeletal muscle injury caused by Bothrops asper venom: its activity appears protective during acute ischemia but can restrain later angiogenic signaling. Using lumiracoxib in a mouse injury model, the authors connect COX-2 pathway modulation with prostaglandins, CD31, VEGF, and matrix metalloproteinases involved in microvascular repair.

• GM 6001 (Galardin): From MMPs to Memory

  2026-08-25

  GM 6001 (Galardin) is a broad-spectrum MMP inhibitor that can help translational researchers test how extracellular matrix proteolysis shapes tissue repair, signaling, cancer phenotypes, vascular remodeling, and hippocampal perineuronal-net integrity. This article connects the compound’s pharmacology with recent Alzheimer’s disease findings while defining the controls needed to move from mechanistic observation to credible translational evidence.

• MLN4924 HCl salt for Reliable Viability Assays

  2026-08-24

  Learn how MLN4924 HCl salt (SKU A3629), a selective NEDD8-activating enzyme inhibitor, can support reproducible viability, proliferation, and pathway-validation workflows. This scenario-based guide covers assay compatibility, dosing, stability, interpretation, and practical product-selection criteria.

• Sildenafil Citrate for Vascular Signaling Research

  2026-08-24

  Build reproducible PDE5 inhibition workflows for cGMP, vascular smooth muscle relaxation, PASMC signaling, and erectile dysfunction research. This guide also shows how native-membrane proteoform analysis can expose PDE6 off-target behavior that conventional bulk assays may miss.

• WZ4003: A Translational Lens on NUAK Signaling

  2026-08-23

  WZ4003 offers a mechanistically anchored way to interrogate NUAK1/2 signaling across cancer biology and tau-related neurodegeneration. Its value lies not only in kinase potency, but in the combination of target-engagement controls, phenotype-linked assays, and human brain-slice evidence that can sharpen translational decision-making.

• Flavopiridol: From CDK Arrest to Translational Insight

  2026-08-22

  Flavopiridol, also known as L868275, offers translational researchers a way to connect CDK-dependent proliferation with apoptosis, transcriptional control, and cellular stress. This thought-leadership perspective links its cancer research utility to endoplasmic reticulum stress biology while distinguishing established evidence from forward-looking hypotheses.

• Cy5 NHS ester(Et): Practical Labeling Guide

  2026-08-22

  Cy5 NHS ester(Et) is a water-soluble amine-reactive dye for covalent fluorescent labeling of proteins, peptides, and other biomolecules. It is suitable for protein fluorescent labeling, immunofluorescence staining, flow cytometry, and fluorescence microscopy, but not for ethanol-based workflows or long-term storage of prepared dye solutions.

• Radicicol: Hsp90 Inhibitor Workflows

  2026-08-21

  Radicicol provides a practical pharmacological probe for Hsp90-dependent signaling across adipocyte differentiation, ovarian carcinoma apoptosis, and immune-cell antigen processing. This guide connects validated product characteristics with executable assay workflows, controls, and troubleshooting strategies for reproducible bench studies.

• ERK5 and ERK1/2 in Vitamin D–Driven AML Differentiation

  2026-08-20

  Wang et al. show that ERK5 and ERK1/2 make distinct contributions to 1α,25-dihydroxyvitamin D3-induced differentiation of acute myeloid leukemia cells. Their pharmacological comparison links ERK5 inhibition to altered myeloid marker expression and G1/G2 cell-cycle arrest, while MEK1/2-ERK1/2 inhibition broadly suppresses differentiation-associated markers.

• CDK4/6 and BET Inhibition in Pancreatic Cancer

  2026-08-20

  Gu et al. show that palbociclib can restrain PDAC proliferation while paradoxically increasing migration, invasion, and epithelial-to-mesenchymal transition. Combining CDK4/6 inhibition with the BET inhibitor JQ1 restored anti-invasive activity through regulation of GSK3β-mediated Wnt/β-catenin signaling and produced synergistic antitumor effects in vitro and in an orthotopic mouse model.

• TAI-1: Hec1 Inhibitor Evidence and Workflows

  2026-08-19

  TAI-1 is a potent Hec1 inhibitor that disrupts Hec1–Nek2 signaling and produces a reported GI50 of 13.48 nM in K562 cells. Product information describes broad anticancer activity, oral efficacy in several preclinical models, and preliminary selectivity findings, while peer-reviewed RB1 organoid research defines a separate biological rationale and important translational limits.

• WM-8014: From KAT6A Biology to Causal Assays

  2026-08-19

  WM-8014 is a reversible KAT6A inhibitor for connecting epigenetic perturbation with senescence, cell-cycle, and tumor-growth phenotypes. This guide shows how to translate time-gated CRISPR insights into better causal assays while defining the compound’s practical limits.

• Z-WEHD-FMK in Pyroptosis and Caspase Research

  2026-08-18

  Z-WEHD-FMK provides cell-permeable, irreversible inhibition of inflammatory caspases for dissecting pyroptosis, infection-associated Golgi remodeling, and caspase-dependent cell death. This guide translates the HOXC8–caspase-1 study into practical assay designs while highlighting solvent control, timing, and specificity considerations.

• U 46619: From TP Signaling to Translation

  2026-08-18

  U 46619, also known as 11,9 epoxymethano-prostaglandin H2, provides a controllable TP-receptor stimulus for connecting platelet signaling, vascular tone, renal hemodynamics, and hypertension models. This thought-leadership guide shows how to use concentration-resolved phenotyping and disciplined translational boundaries to turn a potent research agonist into a strategic experimental benchmark.

743 records 7/50 page Previous Next First page 上5页 678910 下5页 Last page